Vehant Technologies has launched MilliView, India's first indigenous Millimetre-Wave body scanner designed to detect non-metallic threats. ...

AstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...

Precision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...

India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...

India's healthcare sector has seen a major transformation over the last 12 years. Health insurance coverage has expanded significantly. Mat...

British pharmaceutical giant GSK has announced a massive $10.6 billion deal to acquire Nuvalent. This Boston-based company specializes in c...

Industrial pollution in the Ganga has significantly decreased by almost 60 percent since 2017. This achievement is credited to the Namami G...

Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...

Recent reports suggest that Tiger Woods and Vanessa Trump are not on the verge of a breakup despite facing major personal challenges. Woods...

West Bengal is exploring ways to expand electronics manufacturing under EMC 2.0. This and more in today's ETtech Top 5.

Nvidia board member Tench Coxe and his wife Simone Coxe have donated $100 million for a new medical center in Austin, Texas. This significa...

The Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a ...

A new blood test can predict lung cancer more than five years before diagnosis. This breakthrough offers hope for early detection in India....

A second case of the flesh-eating screwworm parasite has been confirmed in Texas. This new detection is just miles from the first U.S. case...

As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

The study, which followed patients for over five years, found that those ⁠who received ⁠the regimen were nine times more likely to have lit...

Novartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...